[ Price : $8.95]
A Senate bill seeks to bar conflicts of interest in consulting contracts, such as those FDA signed with McKinsey & Co. on regulato...[ Price : $8.95]
FDA approves a Staar Surgical PMA for the EVO/EVO+ Visian Implantable Collamer Lens for correcting myopia and myopia with astigmat...[ Price : $8.95]
Federal Register notice: FDA corrects an 8/16/2021 notice entitled Prescription Drug User Fee Rates for Fiscal Year 2022.[ Price : $8.95]
Reblozyl is currently approved to address transfusion-dependent anemia-associated beta thalassemia and lower-risk myelodysplastic ...[ Price : $8.95]
Bristol-Myers Squibb says it has resolved manufacturing constraints that led to global supply challenges for Abraxane for injectab...[ Price : $8.95]
FDA clears a Cutera 510(k) for AviClear, a laser treatment for mild, moderate, and severe acne.[ Price : $8.95]
Ongoing FDA concerns about PI3K inhibitors prompts the agency to discourage MEI Pharma and Kyowa Kirin from seeking accelerated ap...[ Price : $8.95]
The House Oversight and Reform committee asks FDA for answers to what regulatory enforcement actions it sought against Medtronics ...